ZH
RU
ES
artificial cell
artificial cell, Total:213 items.
In the international standard classification, artificial cell involves: Biology. Botany. Zoology, Medical sciences and health care facilities in general, Mathematics, Microbiology, Astronomy. Geodesy. Geography, Laboratory medicine, Applications of information technology, Water quality, Materials and articles in contact with foodstuffs, Construction materials, Medical equipment, Cutting tools, Occupational safety. Industrial hygiene, Pharmaceutics, Products of the chemical industry, Sterilization and disinfection, Textile fibres, Wood-based panels, Dentistry, Veterinary medicine, Farming and forestry, Protection against crime, Vocabularies, Products of the textile industry.
Group Standards of the People's Republic of China, artificial cell
- T/CSCB 0004-2021 Human hematopoietic stem/progenitor cell
- T/LNSI 004-2023 Human cytokine induced killer cell
- T/CSCB 0007-2021 Human cardiomyocyte
- T/CSCB 0002-2020 Human embryonic stem cell
- T/CSCB 0008-2021 Primary human hepatocyte
- T/CSCB 0004-2022 Human neural stem cell
- T/CSSCR 002-2019 human embryonic stem cells
- T/CRHA 002-2021 Human pluripotent stem cell derived small extracellular vesicles
- T/CSCB 0002-2022 Human Natural Killer Cells
- T/CSCB 0003-2021 Human mesenchymal stem cell
- T/CRHA 001-2021 Human mesenchymal stem cell derived small extracellular vesicles
- T/CSCB 0007-2022 General requirements for production of extracellular vesicles derived from human stem cells
- T/CSCB 0005-2021 Human induced pluripotent stem cell
- T/LNSI 002-2023 Human amniotic epithelial stem cells
- T/SRA 001-2019 Standards for establishment of seed cell bank of human adipose-derived mesenchymal stem cells
- T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
- T/LNSI 001-2023 Human amniotic mesenchymal stem cells
- T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry
- T/CSCB 0006-2021 Human retinal pigment epithelial cell
- T/CMBA 014-2021 Guideline for autologous hematopoietic stem cell transplantation
- T/SDHCST 001-2022 Technical Specification for Artificially Induced Pluripotent Stem Cells to Differentiate into Neural Cells
- T/CSCB 0003-2022 Human Midbrain Dopaminergic Progenitor
- T/CSCB 0001-2022 Technical Specification for Ethics Review of Human Stem Cell Research
- T/SDHCST 002-2021 Human umbilical cord/placental mesenchymal stem cell public library
- T/SDHCST 005-2022 Technical Specification of identification for Artificially Induced Pluripotent Stem Cells
- T/SDHCST 004-2022 Technical Specification for Artificially Induced Pluripotent Stem Cells
- T/CRHA 003-2021 Laboratory-General requirements for testing of human-derived stem cell
- T/SRA 002-2019 Standards for Quality Assurance of Human Adipose-derived Mesenchymal Stem Cells
- T/SRA 003-2019 Standards for Quality Assurance of Human Umbilical Cord Mesenchymal Stem Cells
- T/CAME 49-2022 Construction and equipment standard of hematopoietic stem cell transplantation ward
- T/LTIA 10-2020 Regulations for Preparation of Lyophilized Powder from Human Umbilical Cord Mesenchymal Stem Cell
- T/SDHCST 003-2021 Standard Practice for Preparation of Human Umbilical Cord/Placental Mesenchymal Stem Cells
- T/LTIA 17-2022 Guidelines for the detection of genomic instability in human cells
- T/CMBA 011-2020 Collection, Separation and Preservation of PBMC from Human Peripheral Blood
- T/ZHYX 001-2023 General requirements for preparation of human umbilical cord mesenchymal stem cells for clinical use
- T/SDHCST 004-2021 Technical conditions and requirements for human umbilical cord/placental mesenchymal stem cell products
- T/XSMIA 0006-2022 Accreditation of cell Bank
- T/ZGKSL 009-2023 Test method for determination of collagen secreted from human cells induced by recombinant collagen
- T/CRHA 017-2023 Operational Guidelines for Construction, Quality Control and Preservation of Human Liver Progenitor Cell Organoids
- T/CRHA 018-2023 Operational Guidelines for Construction, Quality Control and Preservation of Human Hepatobiliary Tumor Cell Organoids
- T/ZHCA 021-2022 In vitro human fibroblast activity test method for cosmetic firming efficacy test
- T/SBX 047-2021 Determination of α-Galactosidase Activity in Human Peripheral Blood Leukocytes by Microplate Reader Assay
- T/ZHCA 020-2022 Cosmetic Repair Efficacy Test In Vitro Human Fibroblast Migration Ability Test Method
- T/SBX 049-2021 Determination of β-glucocerebrosidase Activity in Human Peripheral Blood Leukocytes by Microplate Reader Assay
- T/SBX 048-2021 Determination of α-L-iduronidase Activity in Human Peripheral Blood Leukocytes by Microplate Reader Assay
- T/CSUS 31-2021 Determination of estrogen activity in water quality water and wastewater In vitro human cell reporter gene test method
- T/ZHCA 010-2020 Method of skin sensitization test in vitro for hair dye cosmetic products-Human cell line activation test
- T/JPMA 008-2020 The technical specification practices of medicinal nano-sized iron oxide tracers labeling clinical grade human umbilical cord mesenchymal stem cells
- T/CSBME 050-2022 Artificial intelligence medical devices for cervical liquid-based cytology— Quality requirements and evaluation— Part 1: requirements for datasets
- T/ZHCA 011-2020 Method of skin sensitization test in vitro for freckle removing and whitening cosmetic products-Human cell line activation test
- T/GDPHA 001-2023 Clinical Practice Guidelines for Subarachnoid Transplantation of Human Mesenchymal Stem Cells for the Treatment of Traumatic Spinal Cord Injury
Canadian Standards Association (CSA), artificial cell
US-FCR, artificial cell
Professional Standard - Agriculture, artificial cell
- 1318药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Macrophage Stimulating Factor
- 584药典 化学药和生物制品卷-2010 Chapter VIII Drugs for Blood System Section 1 Drugs for Raising Blood Cells 2. Drugs for Raising Leukocytes Recombinant Human Granulocyte Macrophage Stimulating Factor
- 149药典 三部-2020 Monograph II Therapeutic Human Granulocyte Macrophage Stimulating Factor for Injection
- 150药典 三部-2020 Monograph Ⅱ Therapeutic topical human granulocyte macrophage stimulating factor gel
- 1324药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interleukin-11
- 583药典 化学药和生物制品卷-2010 Chapter VIII Drugs for Blood System Section 1 Drugs for Raising Blood Cells 2. Drugs for Raising Leukocytes Recombinant Human Granulocyte Stimulating Factor
- 142药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
- 1317药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Stimulating Factor
- 118药典 三部-2010 Chapter II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
- 259药典 三部-2010 Appendix Ⅹ XR Anti-human T cell immunoglobulin titer assay (lymphocytotoxicity test)
- 247药典 三部-2010 Appendix Ⅹ XF Determination of Biological Activity of Recombinant Human Granulocyte Macrophage Stimulating Factor
- 238药典 三部-2010 Appendix IX IXQ Human Erythrocyte Antibody Assay
- 306药典 三部-2020 Bioassay 3426 Human Erythrocyte Antibody Assay
- 337药典 三部-2020 Biological Activity-Potency Assay 3526 Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- 262药典 四部-2015 3400 biological assay 3426 human erythrocyte antibody assay
- 255药典 四部-2020 3400 biological assay 3426 human erythrocyte antibody assay
- 327药典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 65药典 三部-2020 Monograph Ⅰ Prophylactic freeze-dried rabies vaccine for human use (human diploid cells)
- 289药典 四部-2015 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- 279药典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 274药典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 284药典 四部-2020 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- 124药典 三部-2020 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 125药典 三部-2020 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 148药典 三部-2020 Monograph Ⅱ Therapeutic human granulocyte-stimulating factor injection
- 113药典 三部-2015 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 114药典 三部-2015 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 1021药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drugs Recombinant Human Granulocyte Macrophage Stimulating Factor
- 281药典 三部-2015 Bioassay 3426 General Principles of Human Erythrocyte Antibody Assay 118
- 58药典 三部-2015 Monograph Ⅰ Prophylactic freeze-dried rabies vaccine for human use (Vero cells)
- 64药典 三部-2020 Monograph Ⅰ Prophylactic freeze-dried rabies vaccine for human use (Vero cells)
- 116药典 三部-2015 Monograph II Therapeutic Recombinant Human Erythropoin Injection (CHO Cell)
- 115药典 三部-2015 Monograph II Therapeutic Recombinant Human Erythropoin for Injection (CHO Cell)
- 37药典 三部-2010 Contents of each monograph Ⅰ Prophylactic rabies vaccine for humans (Vero cells)
- 298药典 三部-2015 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test) General 129
- 308药典 三部-2015 Biological Activity - Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay General Rules 135
- 67药典 三部-2015 Monograph Ⅰ Prevention of Rubella Live Attenuated Vaccine (Human Diploid Cells)
- 74药典 三部-2020 Monograph Ⅰ Prevention of Rubella Live Attenuated Vaccine (Human Diploid Cells)
- 141药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Stimulating Factor Injection
- 1321药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Erythropoin
- 92药典 三部-2010 Chapter Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulin
- 91药典 三部-2010 Chapter Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 60药典 三部-2015 Monograph Ⅰ Prophylaxis of Inactivated Hepatitis A Vaccine (Human Diploid Cells)
- 67药典 三部-2020 Monograph Ⅰ Prophylaxis of Inactivated Hepatitis A Vaccine (Human Diploid Cells)
- 1313药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interferon α2a
- 1314药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interferon α2b
- 1315药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interferon β
- 1322药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interleukin-2
- 1316药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interferon γ
- 126药典 三部-2010 Chapter Ⅱ Therapeutic class Anti-human T cell CD3 mouse monoclonal antibody for injection
- 1312药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interferon α1b
- 38药典 三部-2010 Contents of each monograph Ⅰ Preventive freeze-dried human rabies vaccine (Vero cells)
- 93药典 三部-2010 Chapter II Therapeutic Recombinant Human Erythropoin for Injection (CHO Cell)
- 94药典 三部-2010 Chapter II Therapeutic Recombinant Human Erythropoin Injection (CHO Cell)
- 39药典 三部-2010 Chapter Ⅰ Prophylactic Rabies Vaccine for Humans (Hamster Kidney Cells)
- 117药典 三部-2010 Chapter II Therapeutic Recombinant Human Granulocyte Stimulating Factor Injection
- 48药典 三部-2010 Monographs, Contents Ⅰ Prevention of Rubella Live Attenuated Vaccines (Human Diploid Cells)
- 1020药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Group A Streptococcus, etc. Interferon α2a Recombinant Human Interferon α2b Recombinant Human Interferon β Recombinant Human Interferon γ Recombinant Human Granulocyte Stimulating
- 245药典 三部-2020 Content Determination Method 3124 Human Granulocyte Stimulating Factor Protein Content Determination Method
- 194药典 三部-2010 Appendix VI VIU Determination of Recombinant Human Granulocyte Stimulating Factor Protein Content
- 1323药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Thrombopoietin
- 1319药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokines Recombinant Human Epidermal Growth Factor
- 41药典 三部-2010 Contents of each monograph Ⅰ Prophylaxis of inactivated vaccine against hepatitis A (human diploid cells)
- 246药典 三部-2010 Appendix Ⅹ XE Recombinant human granulocyte-stimulating factor biological activity assay
- 1311药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 3. Blood Products Anti-Human T Cell Immunoglobulin
- 1330药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 6. Monoclonal Antibody Anti-Human T Cell CD3 Mouse Monoclonal Antibody
- 75药典 三部-2015 Monograph Ⅰ Prevention of poliomyelitis-like live attenuated vaccine sugar pill (human diploid cells)
- 82药典 三部-2020 Monograph Ⅰ Prevention of poliomyelitis-like live attenuated vaccine sugar pill (human diploid cells)
- 1258药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Anti-Human T Cell CD3 Mouse Monoclonal Antibody
- 218药典 四部-2015 3100 Content Determination 3124 Recombinant Human Granulocyte Stimulating Factor Protein Content Determination
- 206药典 四部-2020 3100 Content Determination 3124 Recombinant Human Granulocyte Stimulating Factor Protein Content Determination
- 1259药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs against Human T Cell Immunoglobulin
- 336药典 三部-2020 Biological Activity-Potency Assay 3525 Human Granulocyte Stimulating Factor Biological Activity Assay
- 56药典 三部-2010 Contents of each monograph Ⅰ Prevention of poliomyelitis-like live attenuated vaccine sugar pill (human diploid cells)
- 226药典 三部-2015 Content Assay 3124 Recombinant Human Granulocyte Stimulating Factor Protein Assay General Rules 62
- 85药典 三部-2020 Monograph Ⅰ Preventive Oral Type I Type Ⅲ Poliomyelitis Live Attenuated Vaccine (Human Diploid Cells)
- 580药典 化学药和生物制品卷-2010 Chapter VIII Drugs for the Blood System Section 1 Drugs for Raising Blood Cells 1. Anti-anemia Drug Recombinant Human Erythropoin
- 588药典 化学药和生物制品卷-2010 Chapter 8 Medications for Blood System Section 1 Drugs for Raising Blood Cells 3. Drugs for Raising Platelets Human Albumin
- 288药典 四部-2015 3500 Biological activity-potency assay 3525 Recombinant human granulocyte-stimulating factor biological activity assay
- 283药典 四部-2020 3500 Biological activity-potency assay 3525 Recombinant human granulocyte-stimulating factor biological activity assay
- 258药典 三部-2010 Appendix Ⅹ XQ Anti-human T cell immunoglobulin titer assay (E rosette formation inhibition test)
- 585药典 化学药和生物制品卷-2010 Chapter 8 Medications for Blood System Section 1 Drugs for Boosting Blood Cells 3. Drugs for Boosting Platelets Recombinant Human Interleukin-11
- 307药典 三部-2015 Biological activity-potency assay 3525 Recombinant human granulocyte-stimulating factor biological activity assay general rules 134
- 1252药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Rat Anti-Human T Lymphocyte CD3 Antigen Monoclonal Antibody
American Society for Testing and Materials (ASTM), artificial cell
- ASTM E2526-22 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM E2526-08(2013) Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM E2526-08 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
Association Francaise de Normalisation, artificial cell
- CWA 15849:2008 Coding of Information and Traceability of Human Tissues and Cells
- NF EN 14486:2006 Qualité de l'eau - Détection des entérovirus humains par culture cellulaire par la méthode des plages
- NF EN 111001:1991 Spécification particulière cadre : tubes à rayons cathodiques
- NF P41-290:2008 Effect of materials on the quality of water intented for human consumption - Cytotoxicity measurement method.
- NF U47-221:2010 Isolation on cell culture and identification by immunofluorescence of infectious haematopoietic necrosis virus of fish.
Guangdong Provincial Standard of the People's Republic of China, artificial cell
- DB4403/T 122-2020 Technical specifications for the establishment of human tumor cell lines
- DB4403/T 121-2020 Transportation technology and management regulations of human cell products
Zhejiang Provincial Standard of the People's Republic of China, artificial cell
- DB33/T 2030-2017 Standards for construction and management of human mesenchymal stem cell bank
Shaanxi Provincial Standard of the People's Republic of China, artificial cell
- DB61/T 1497-2021 Standards for construction and management of human mesenchymal stem cell bank
British Standards Institution (BSI), artificial cell
- BS PAS 93:2011 Characterization of human cells for clinical applications. Guide
- BS CWA 15849:2008 Coding of information and traceability of human tissues and cells
- BS PAS 83:2012 Developing human cells for clinical applications in the European Union and the United States of America. Guide
- BS ISO 18362:2016+A1:2022 Manufacture of cell-based health care products. Control of microbial risks during processing
- BS ISO 24603:2022 Biotechnology. Biobanking. Requirements for human and mouse pluripotent stem cells
- BS ISO 19040-3:2018 Water quality. Determination of the estrogenic potential of water and waste water. In vitro human cell-based reporter gene assay
- 21/30419760 DC BS ISO 24603. Biotechnology. Biobanking. Requirements for human and mouse pluripotent stem cells
- BS EN ISO 19040-3:2022 Water quality. Determination of the estrogenic potential of water and waste water - In vitro human cell-based reporter gene assay
- BS ISO 24651:2022 Biotechnology. Biobanking. Requirements for human mesenchymal stromal cells derived from bone marrow
- BS ISO 18362:2016 Manufacture of cell-based health care products. Control of microbial risks during processing
- 21/30427340 DC BS EN ISO 18362 AMD1. Manufacture of cell-based health care products. Control of microbial risks during processing
- PD ISO/TS 22859-1:2022 Biotechnology. Biobanking. Requirements for human mesenchymal stromal cells derived from umbilical cord tissue
- 21/30419763 DC BS ISO 24651. Biotechnology. Biobanking. Requirements for human mesenchymal stromal cells derived from bone marrow
- PD ISO/TS 23565:2021 Biotechnology. Bioprocessing. General requirements and considerations for equipment systems used in the manufacturing of cells for therapeutic use
Professional Standard - Medicine, artificial cell
- YY/T 1180-2010 Typing kit for human leucocyte antigen (HLA).Sequence specific primer.SSP
American National Standards Institute (ANSI), artificial cell
国家药监局, artificial cell
- YY/T 1180-2021 Human Leukocyte Antigen (HLA) Genotyping Test Kit
- YY/T 1688-2021 Blastocyst cell staining and counting methods for medical devices used in human assisted reproductive technology
CU-NC, artificial cell
卫生健康委员会, artificial cell
- WS/T 785-2021 Technical standards for human leukocyte antigen genotyping detection system
CZ-CSN, artificial cell
International Organization for Standardization (ISO), artificial cell
- ISO 24603:2022 Biotechnology — Biobanking — Requirements for human and mouse pluripotent stem cells
- ISO 13609:2014 Wood-based panels — Plywood — Blockboards and battenboards
- ISO 24651:2022 Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow
- ISO 13022:2012 Medical products containing viable human cells - Application of risk management and requirements for processing practices
- ISO 18362:2016 Manufacture of cell-based health care products - Control of microbial risks during processing
- ISO/TS 22859:2022 Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue
- ISO 18362:2016/Amd 1:2022 Manufacture of cell-based health care products — Control of microbial risks during processing — Amendment 1
- ISO 19040-3:2018 Water quality - Determination of the estrogenic potential of water and waste water - Part 3: In vitro human cell-based reporter gene assay
- ISO/TS 23565:2021 Biotechnology — Bioprocessing — General requirements and considerations for equipment systems used in the manufacturing of cells for therapeutic use
Taiwan Provincial Standard of the People's Republic of China, artificial cell
- CNS 7842-1981 Method of Test for Capillarity of Artificial Abrasives
Japanese Industrial Standards Committee (JISC), artificial cell
- JIS R 6127:1969 Testing method for capillarity of artificial abrasives
- JIS T 0301:2000 Testing method for biocompatibility of implantable metals using cultured cells
Occupational Health Standard of the People's Republic of China, artificial cell
- GBZ/T 243-2013 Specification of dose estimation for the radiation victims in the early stage using single cell gel electrophoresis
- GBZ/T(卫生) 243-2013 Specification of dose estimation for the radiation victims in the early stage using single cell gel electrophoresis
- GBZ/T 248-2014 Test and assessment of chromosomal aberrations on occupational health examinations for radiation workers
- GBZ/T(卫生) 248-2014 Test and assessment of chromosomal aberrations on occupational health examinations for radiation workers
国家食品药品监督管理局, artificial cell
- YY/T 1500-2016 Medical device pyrogen test Monocyte activation test Human whole blood ELISA method
German Institute for Standardization, artificial cell
- DIN EN ISO 18362:2018-11 Manufacture of cell-based health care products - Control of microbial risks during processing (ISO 18362:2016); German and English version prEN ISO 18362:2018 / Note: Date of issue 2018-09-28
- DIN ISO 13022:2014-06 Medical products containing viable human cells - Application of risk management and requirements for processing practices (ISO 13022:2012)
- DIN EN ISO 18362:2018 Manufacture of cell-based health care products - Control of microbial risks during processing (ISO 18362:2016); German and English version prEN ISO 18362:2018
- DIN ISO 13022:2014 Medical products containing viable human cells - Application of risk management and requirements for processing practices (ISO 13022:2012)
Korean Agency for Technology and Standards (KATS), artificial cell
- KS L 6515-2002 Testing method for capillarity of artificial abrasives
- KS P ISO 13022:2018 Medical products containing viable human cells — Application of risk management and requirements for processing practices
Jiangsu Provincial Standard of the People's Republic of China, artificial cell
- DB32/T 3544-2019 Clinical-grade human tissue-derived mesenchymal stem cells quality control management regulations
Indonesia Standards, artificial cell
- SNI 08-0589-1989 Staple synthetic fibres, Test method for fineness (weighing method)
GOSTR, artificial cell
- GOST 34660-2020 Methods of testing the impact of chemical products on the human body. Micronucleus analysis on the erythrocytes of mammals
- GOST 34659-2020 Methods of testing the impact of chemical products on the human body. Assessment of chromosomal aberrations in bone marrow cells mammals
Professional Standard - Public Safety Standards, artificial cell
- GA/T 1997-2022 Forensic Science Basic Requirements for the Quality of Memory Cards for Human Saliva/Oral Cell Sample Collection
RU-GOST R, artificial cell
- GOST R ISO 13022-2016 Medical products containing viable human cells. Application of risk management and requirements for processing practices
KR-KS, artificial cell
- KS P ISO 13022-2018 Medical products containing viable human cells — Application of risk management and requirements for processing practices
US-AAMI, artificial cell
- ANSI/AAMI/ISO 13022:2012 Medical products containing viable human cells.Application of risk management and requirements for processing practices
Standard Association of Australia (SAA), artificial cell
- AS 2252.5:2017 Controlled environments, Part 5: Cytotoxic drug safety cabinets (CDSC) — Design, construction, installation, testing and use
European Committee for Standardization (CEN), artificial cell
- EN ISO 19040-3:2022 Water quality - Determination of the estrogenic potential of water and waste water - Part 3: In vitro human cell-based reporter gene assay (ISO 19040-3:2018)
PT-IPQ, artificial cell
- NP 2920-1988 Rubber, vulcanized Time interval between vulcanization and testing. Specifications
United States Navy, artificial cell
Danish Standards Foundation, artificial cell
- DS/ISO/TS 23565:2021 Biotechnology – Bioprocessing – General requirements and considerations for equipment systems used in the manufacturing of cells for therapeutic use